| Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019 J Zhao, Q Yuan, H Wang, W Liu, X Liao, Y Su, X Wang, J Yuan, T Li, J Li, ... Clinical infectious diseases 71 (16), 2027-2034, 2020 | 3405 | 2020 |
| Treatment of 5 critically ill patients with COVID-19 with convalescent plasma C Shen, Z Wang, F Zhao, Y Yang, J Li, J Yuan, F Wang, D Li, M Yang, ... Jama 323 (16), 1582-1589, 2020 | 2858 | 2020 |
| Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China A Wu, Y Peng, B Huang, X Ding, X Wang, P Niu, J Meng, Z Zhu, Z Zhang, ... Cell host & microbe 27 (3), 325-328, 2020 | 2827 | 2020 |
| Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Y Liu, Y Yang, C Zhang, F Huang, F Wang, J Yuan, Z Wang, J Li, J Li, ... Science China Life Sciences 63, 364-374, 2020 | 2434 | 2020 |
| Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 M Liao, Y Liu, J Yuan, Y Wen, G Xu, J Zhao, L Cheng, J Li, X Wang, ... Nature medicine 26 (6), 842-844, 2020 | 2328 | 2020 |
| Human neutralizing antibodies elicited by SARS-CoV-2 infection B Ju, Q Zhang, J Ge, R Wang, J Sun, X Ge, J Yu, S Shan, B Zhou, S Song, ... Nature 584 (7819), 115-119, 2020 | 1781 | 2020 |
| Experimental treatment with favipiravir for COVID-19: an open-label control study Q Cai, M Yang, D Liu, J Chen, D Shu, J Xia, X Liao, Y Gu, Q Cai, Y Yang, ... Engineering 6 (10), 1192-1198, 2020 | 1560 | 2020 |
| The global burden of liver disease: the major impact of China FS Wang, JG Fan, Z Zhang, B Gao, HY Wang Hepatology 60 (6), 2099-2108, 2014 | 1458 | 2014 |
| Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020 J Liu, X Liao, S Qian, J Yuan, F Wang, Y Liu, Z Wang, FS Wang, L Liu, ... Emerging infectious diseases 26 (6), 1320, 2020 | 1172 | 2020 |
| Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses F Qi, S Qian, S Zhang, Z Zhang Biochemical and biophysical research communications 526 (1), 135-140, 2020 | 1027 | 2020 |
| Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients J Fu, D Xu, Z Liu, M Shi, P Zhao, B Fu, Z Zhang, H Yang, H Zhang, C Zhou, ... Gastroenterology 132 (7), 2328-2339, 2007 | 982 | 2007 |
| Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility J Zhao, Y Yang, H Huang, D Li, D Gu, X Lu, Z Zhang, L Liu, T Liu, Y Liu, ... Clinical Infectious Diseases 73 (2), 328-331, 2021 | 971 | 2021 |
| CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells KE Wang, W Chen, Z Zhang, Y Deng, JQ Lian, P Du, D Wei, Y Zhang, ... Signal transduction and targeted therapy 5 (1), 283, 2020 | 908 | 2020 |
| Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections Y Yang, M Yang, C Shen, F Wang, J Yuan, J Li, M Zhang, Z Wang, L Xing, ... MedRxiv, 2020.02. 11.20021493, 2020 | 773 | 2020 |
| SARS-CoV-2 invades host cells via a novel route: CD147-spike protein K Wang, W Chen, YS Zhou, JQ Lian, Z Zhang, P Du, L Gong, Y Zhang, ... biorxiv, 2020.03. 14.988345, 2020 | 757 | 2020 |
| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ... Cell 182 (6), 1401-1418. e18, 2020 | 753 | 2020 |
| Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 Y Yang, C Shen, J Li, J Yuan, J Wei, F Huang, F Wang, G Li, Y Li, L Xing, ... Journal of Allergy and Clinical Immunology 146 (1), 119-127. e4, 2020 | 681 | 2020 |
| COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas X Ren, W Wen, X Fan, W Hou, B Su, P Cai, J Li, Y Liu, F Tang, F Zhang, ... Cell 184 (7), 1895-1913. e19, 2021 | 643 | 2021 |
| Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B JY Zhang, Z Zhang, F Lin, ZS Zou, RN Xu, L Jin, JL Fu, F Shi, M Shi, ... Hepatology 51 (1), 81-91, 2010 | 595 | 2010 |
| PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients F Shi, M Shi, Z Zeng, RZ Qi, ZW Liu, JY Zhang, YP Yang, P Tien, FS Wang International journal of cancer 128 (4), 887-896, 2011 | 543 | 2011 |
Juanjuan ZhaoInstitute of Hepatology,National Clinical Research Center for Infectious Disease, Shenzhen在 moon.ibp.ac.cn 的电子邮件经过验证
